Center for Urogynecology and Pelvic Surgery, Department of Obstetrics and Gynecology, Christiana Care Health Services, Newark, DE 19713, USA.
J Womens Health (Larchmt). 2012 Apr;21(4):440-6. doi: 10.1089/jwh.2011.2952. Epub 2012 Jan 30.
To investigate the association between beliefs about medications and primary adherence in women prescribed anticholinergic medications for urgency urinary incontinence (UUI).
We enrolled 160 women with UUI who were prescribed anticholinergic medications between 2009 and 2010. Validated questionnaires were administered to measure the diagnosis of UUI, its impact on quality of life, and beliefs about medications. Primary adherence, filling of a prescription within 30 days, was measured through pharmacy records. The association between healthcare beliefs and primary adherence was measured using multivariable analysis.
The incidence of primary adherence to anticholinergic medication was 73%. Of the women, 5% reported belief in the general harm of medicines, 31% reported belief in the general overuse of medicines, and 90% reported belief in the general benefit of medicines. Responses to the Beliefs about Medicines Questionnaire (BMQ) had good internal consistency in women with UUI (Cronbach's alpha 0.59-0.75). On univariable analysis, belief in the general overuse of medicines (odds ratio [OR] 0.48, 95% confidence interval [CI] 0.23-0.99) and belief in the general harm of medicines (OR 0.11, 95% CI 0.02-0.57) were significant negative predictors of primary adherence to anticholinergic medications. A significant relationship between the impact of urinary symptoms on quality of life and primary adherence was not noted (OR 1.02, 95% CI 0.86-1.22). On multivariable analysis, belief in the general overuse of medicines remained a significant negative predictor of primary adherence (OR 0.35, 95% CI 0.16-0.79).
Women with UUI who believe that medicines in general are overused are less likely to fill their prescriptions for anticholinergic medications.
调查女性服用抗胆碱能药物治疗急迫性尿失禁(UUI)时,对药物的信念与主要依从性之间的关系。
我们招募了 160 名在 2009 年至 2010 年间被开处抗胆碱能药物的 UUI 女性患者。采用验证后的问卷评估 UUI 的诊断、对生活质量的影响以及对药物的信念。通过药房记录测量主要依从性(即 30 天内开处方)。使用多变量分析评估医疗保健信念与主要依从性之间的关联。
抗胆碱能药物的主要依从性发生率为 73%。在这些女性中,5%的人报告相信药物普遍有害,31%的人报告相信药物普遍过度使用,90%的人报告相信药物普遍有益。UUI 女性对药物信念问卷(BMQ)的回答具有良好的内部一致性(Cronbach's alpha 0.59-0.75)。单变量分析显示,相信药物普遍过度使用(比值比[OR]0.48,95%置信区间[CI]0.23-0.99)和相信药物普遍有害(OR 0.11,95% CI 0.02-0.57)是抗胆碱能药物主要依从性的显著负预测因素。尿症状对生活质量的影响与主要依从性之间没有显著关系(OR 1.02,95% CI 0.86-1.22)。多变量分析显示,相信药物普遍过度使用仍然是主要依从性的显著负预测因素(OR 0.35,95% CI 0.16-0.79)。
认为药物普遍过度使用的 UUI 女性不太可能开抗胆碱能药物的处方。